title: Morphological study of the effects of the GnRH superagonist deslorelin on the canine testis and prostate gland.
abstract: The present study is part of a programme of research designed to evaluate the efficacy of the GnRH superagonist,deslorelin (D-Trp6-Pro9-des-Gly10-LHRH ethylamide), as a contraceptive for male dogs. Adult dogs were assigned to a completely randomized design comprising six groups of four animals. Each dog in the control group received a blank implant (placebo) and each dog in the other five groups received a 6 mg deslorelin implant. One group of deslorelin treated dogs was sacrificed on each of days 16, 26, 41, 101 and 620, and testicular and prostate tissues were collected for study by light and electron microscopy. On days 16 and 26 after implantation, we observed partial disruption of the seminiferous tubules, with early spermatids shed into the lumen. On days 41 and 101 after implantation, 90–100% of the seminiferous tubules were atrophic and aspermatogenic.On day 101 after implantation, 99% of all sections showed atrophy of the epithelium and shrinkage of epithelial height in the ductus epididymides. On days 41 and 101 after implantation, prostate tissue showed complete atrophy of the glandular epithelium (100% of sections) and an apparent increase in the relative proportion of connective tissue. At the electron microscopic level, in dogs treated with deslorelin for 41 and 101 days, the Sertoli cells were smaller and their nucleoli appeared smaller than in the control dogs. The nucleoli of the Leydig cells were atrophied and prostate glandular epithelium showed reduced epithelial height, a trophy of the nucleolus and an absence of secretory granules.Tissues collected during the recovery phase revealed a complete recovery of spermatogenesis. In conclusion, slow release implants containing deslorelin induce a striking a trophy of the testes and prostate gland by 26 days after implantation, explaining the previously reported loss of ejaculate and arrest of sperm output. At histological level,the entire process appears to be completely reversible, in accordance with data on endocrine variables and semen production.
authors.affiliation: Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, WA, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Junaidi
authors.forename: P E
authors.initials: PE
authors.lastname: Williamson
authors.forename: T E
authors.initials: TE
authors.lastname: Trigg
authors.forename: J M
authors.initials: JM
authors.lastname: Cummins
authors.forename: G B
authors.initials: GB
authors.lastname: Martin
mesh_terms: D000818:Animals; D001284:Atrophy; D003272:Contraceptive Agents, Male / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D008297:Male; D011467:Prostate / Q000187:drug effects* / Q000648:ultrastructure; D013737:Testis / Q000187:drug effects* / Q000648:ultrastructure; D017329:Triptorelin Pamoate / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D003272:Contraceptive Agents, Male; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; C066438:deslorelin